Anti-inflammatory effects of a novel compound, MPQP, through the inhibition of IRAK1 signaling pathways in LPS-stimulated RAW 264.7 macrophages

키워드

참고문헌 (34)

1. Kim E, "Lancemaside A from Codonopsis lanceolata modulates the inflammatory responses mediated by monocytes and macrophages", Mediators Inflamm, 2014, pp.405158~405158 (2014)
2. Nowarski R, "Innate immune cells in inflammation and cancer", Cancer Immunol Res, 1, pp.77~84 (2013)[DOI]
3. Wu LC, "Anti- inflammatory effect of spilanthol from Spilanthes acmella on murine macrophage by down-regulating LPS-induced inflammatory mediators", J Agric Food Chem, 56, pp.2341~2349 (2008)[DOI]
4. Libby P, "Inflammatory mechanisms: the molecular basis of inflammation and disease", Nutr Rev, 65, pp.140~146 (2007)[DOI]
5. Barton GM, "Toll-like receptor signaling pathways", Science, 300, pp.1524~1525 (2003)[DOI]
6. Ordureau A, "The IRAK-catalysed activation of the E3 ligase function of Pellino isoforms induces the Lys63-linked polyubiquitination of IRAK1", Biochem J, 409, pp.43~52 (2008)[DOI]
7. Avila M, "Signaling through Toll-like receptor 4 and mast cell-dependent innate immunity responses", IUBMB Life, 63, pp.873~880 (2011)[DOI]
8. Jiang Z, "Interleukin-1 (IL-1) receptor-associated kinasedependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol", Mol Cell Biol, 22, pp.7158~7167 (2002)[DOI]
9. Schreiber SL, "Chemical genetics resulting from a passion for synthetic organic chemistry", Biorg Med Chem, 6, pp.1127~1152 (1998)[DOI]
10. Thompson LA, "Synthesis and applications of small molecule libraries", Chem Rev, 96, pp.555~600 (1996)[DOI]
11. Weijie Chen, "Ginsenoside Rb1 and compound K improve insulin signaling and inhibit ER stress-associated NLRP3 inflammasome activation in adipose tissue", Journal of Ginseng Research, 40(4), pp.351~358 (2016), 고려인삼학회
12. Byeong-Ju Cha, "Glycosyl glycerides from hydroponic Panax ginseng inhibited NO production in lipopolysaccharide-stimulated RAW264.7 cells", Journal of Ginseng Research, 39(2), pp.162~168 (2015), 고려인삼학회
13. Cho YC., "Thunbergia alata inhibits inflammatory responses through the inactivation of ERK and STAT3 in macrophages", Int J Mol Med, 38, pp.1596~1604 (2016)[DOI]
14. Funk CD, "Prostaglandins and leukotrienes: advances in eicosanoid biology", Sci, 294, pp.1871~1875 (2001)[DOI]
15. Feghali CA, "Cytokines in acute and chronic inflammation", Front Biosci, 2, pp.12~26 (1997)
16. Ma P, "Chitosan oligosaccharides inhibit LPS-induced over-expression of IL-6 and TNF-<TEX>${\alpha}$<", TEX> in RAW264. 7 macrophage cells through blockade of mitogen-activated protein kinase (MAPK) and PI3K, Carbohydr Polym, pp.2011, 84[DOI]
17. Kwak HJ, "Roflumilast inhibits lipopolysaccharideinduced inflammatory mediators via suppression of nuclear factor-<TEX>${\kappa}B$<", TEX>, p38 mitogen-activated protein kinase, and c-Jun NH2-terminal kinase activation, 2005, pp.315, 1188~1195
18. Lee J, "Eupatolide inhibits lipopolysaccharide-induced COX-2 and iNOS expression in RAW264. 7 cells by inducing proteasomal degradation of TRAF6", Eur J Pharmacol, 636, pp.173~180 (2010)[DOI]
19. Finco TS, "Inducible phosphorylation of I kappa B alpha is not sufficient for its dissociation from NF-kappa B and is inhibited by protease inhibitors", Proc Natl Acad Sci U S A, 91, pp.11884~11888 (1994)[DOI]
20. Karin M, "AP-1 function and regulation", Curr Opin Cell Biol, 9, pp.240~246 (1997)[DOI]
21. Plotnikov A, "The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation", Biochim Biophys Acta, 1813, pp.1619~1633 (2011)[DOI]
22. Neu HC, "Quinolone antimicrobial agents", Annu Rev Med, 43, pp.465~486 (1992)[DOI]
23. Abadi AH, "Synthesis of novel 4-substituted-7-trifluoromethylquinoline derivatives with nitric oxide releasing properties and their evaluation as analgesic and anti-inflammatory agents", Biorg Med Chem, 13, pp.5759~5765 (2005)[DOI]
24. Solomon VR, "Quinoline as a privileged scaffold in cancer drug discovery", Curr Med Chem, 18, pp.1488~1508 (2011)[DOI]
25. Kumar S, "Biological activities of quinoline derivatives", Mini Rev Med Chem, 9, pp.1648~1654 (2009)[DOI]
26. Dinarello CA, "Anti-inflammatory agents: present and future", Cell, 140, pp.935~950 (2010)[DOI]
27. Palladino MA, "Anti-TNF-<TEX>${\alpha}$<", TEX> therapies: the next generation, 2003, pp.2, 736~742
28. 김승재, "Corosolic acid ameliorates acute inflammation through inhibition of IRAK-1 phosphorylation in macrophages", BMB Reports, 49(5), pp.276~281 (2016), 생화학분자생물학회
29. Li M, "Interleukin-1 receptor associated kinase 1 is a potential therapeutic target of anti-inflammatory therapy for systemic lupus erythematosus", Mol Immunol, 87, pp.94~101 (2017)[DOI]
30. Nishimoto N, "Interleukin-6 in rheumatoid arthritis", Curr Opin Rheumatol, 18, pp.277~281 (2006)[DOI]
31. Anestakis D, "Mechanisms and applications of interleukins in cancer immunotherapy", Int J Mol Sci, 16, pp.1691~1710 (2015)[DOI]
32. Scheidt-Nave C, "Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause", J Clin Endocrinol Metab, 86, pp.2032~2042 (2001)
33. Smolen JS, "Interleukin-6: a new therapeutic target", Arthrit Res Ther, 8, pp.S5~ (2006)[DOI]
34. Emery P, "IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial", Ann Rheum Dis, 67, pp.1516~1523 (2008)[DOI]

관련 논문AI추천